Astaxanthin reduces the growth of breast cancer cells by inhibiting the PI3K/Akt/mTOR pathway, followed by subsequently blocking translation of the MYC protein, which is essential in oncogenesis [160,161]. Here, MTOR is linked to breast carcinoma.